In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod
Eugenio Cavalli(Centro Neurolesi Bonino Pulejo), Maria Cristina Petralia(University of Messina), Santa Mammana(University of Catania), Maria Sofia Basile(University of Catania), Emanuela Mazzon(Centro Neurolesi Bonino Pulejo), Reni Kalfin(South-West University "Neofit Rilski"), Marko Andabaka(Centar za Promociju Nauke), Manuela Pennisi(University of Catania), Jelena Drulović(University of Belgrade), Šarlota Mesaroš(University of Belgrade), Tatjana Pekmezović(University of Belgrade), Jovana Ivanović(Vita-Salute San Raffaele University), Vanja Martinović(Centar za Promociju Nauke), Ferdinando Nicoletti(University of Catania), Paolo Fagone(University of Catania)
Cited by 32
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495